Semaglutide brand names include Ozempic, Rybelus, and Wegovy, all made by Novo Nordisk, and Mounjaro from Eli Lilly
Semaglutide a medication originally designed to manage type 2 diabetes has rapidly emerged as a sought-after option for weight loss, celebrated for its ability to support significant and sustained reductions in body weight
To achieve that, you have to consume sufficient quantities of sugars aka carbohydrates, so you preserve glycogen stores and slow down the release of cortisol
Conclusion GLP-1 therapies have shown promise in improving heart health and supporting weight loss, with major trials highlighting their ability to reduce key cardiovascular events across a variety of patient groups
Whether you're celebrating a milestone or have a question about a side effect, they're there to help adjust your plan as needed
Sermorelin: A Review of its Use in the Treatment of Growth Hormone Deficiency